Effect of agomelatine and its interaction with the daily corticosterone rhythm on progenitor cell proliferation in the dentate gyrus of the adult rat

Neuropharmacology

Volumn 59, Issue 6, 2010, Pages 375-379

  AlAhmed, Samaher ^a   Herbert, Joe ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

5HT2C receptors; Agomelatine; Hippocampus; Neurogenesis; RO600175; SB24208; Serotonin

Indexed keywords

2 (6 CHLORO 5 FLUORO 1 INDOLYL) 1 METHYLETHYLAMINE; 6 CHLORO 5 METHYL 1 [[2 [(2 METHYL 3 PYRIDYL)OXY] 5 PYRIDYL]CARBAMOYL]INDOLINE; AGOMELATINE; CORTICOSTERONE; FLUOXETINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DENTATE GYRUS; DRUG ANTAGONISM; DRUG MECHANISM; HIPPOCAMPUS; MALE; MITOSIS; NERVOUS SYSTEM DEVELOPMENT; NEURAL STEM CELL; NONHUMAN; PRIORITY JOURNAL; RAT;

ACETAMIDES; ANALYSIS OF VARIANCE; ANIMALS; CELL PROLIFERATION; CIRCADIAN RHYTHM; CORTICOSTERONE; DENTATE GYRUS; IMMUNOHISTOCHEMISTRY; MALE; MELATONIN; NEURAL STEM CELLS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, SEROTONIN, 5-HT2C;

EID: 77956907811     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2010.05.008     Document Type: Article

References (44)

1. AlAhmed S., Herbert J. Strain differences in proliferation of progenitor cells in the dentate gyrus of the adult rat and the response to fluoxetine are dependent on corticosterone. Neuroscience 2008, 157:677-682.
2. Almon R.R., Yang E., Lai W., Androulakis I.P., DuBois D.C., Jusko W.J. Circadian variations in rat liver gene expression: relationships to drug actions. J. Pharmacol. Exp. Ther. 2008, 326:700-716.
3. Audinot V., Mailliet F., Lahaye-Brasseur C., Bonnaud A., Le Gall A., Amosse C., Dromaint S., Rodriguez M., Nagel N., Galizzi J.P., Malpaux B., Guillaumet G., Lesieur D., Lefoulon F., Renard P., Delagrange P., Boutin J.A. New selective ligands of human cloned melatonin MT1 and MT2 receptors. Naunyn Schmiedebergs Arch. Pharmacol. 2003, 367:553-561.
4. Banasr M., Duman R.S. Regulation of neurogenesis and gliogenesis by stress and antidepressant treatment. CNS Neurol. Disord. Drug Targets 2007, 6:311-320.
5. Banasr M., Hery M., Printemps R., Daszuta A. Serotonin-induced increases in adult cell proliferation and neurogenesis are mediated through different and common 5HT receptor subtypes in the dentate gyrus and the subventricular zone. Neuropsychopharmacology 2004, 29:450-460.
6. Banasr M., Soumier A., Hery M., Mocaer E., Daszuta A. Agomelatine, a new antidepressant, induces regional changes in hippocampal neurogenesis. Biol. Psychiatry 2006, 59:1087-1096.
7. Beck-Friis J., Kjellman B.F., Aperia B., Unden F., von Rosen D., Ljunggren J.G., Wetterberg L. Serum melatonin in relation to clinical variables in patients with major depressive disorder and a hypothesis of a low melatonin syndrome. Acta Psychiatr. Scand. 1985, 71:319-330.
8. Bertaina-Anglade V., la Rochelle C.D., Boyer P.A., Mocaer E. Antidepressant like effects of agomelatine (S 20098) in the learned helplessness model. Behav. Pharmacol. 2006, 17:703-713.
9. Boulougouris V., Glennon J.C., Robbins T.W. Dissociable effects of selective 5-HT(2A) and 5-HT(2C) receptor antagonists on serial spatial reversal learning in rats. Neuropsychopharmacology 2008, 33:2007-2019.
10. Bourin M., Mocaer E., Porsolt R. Antidepressant-like activity of S 20098 (agomelatine) in the forced swimming test in rodents: involvement of melatonin and serotonin receptors. J. Psychiatry Neurosci. 2004, 29:126-133.
11. Cameron H.A., Gould E. Adult neurogenesis is regulated by adrenal steroids in the dentate gyrus. Neuroscience 1994, 61:203-209.
12. Chen X., Herbert J. Regional changes in c-fos expression in the basal forebrain and brainstem during adaptation to repeated stress: correlations with cardiovascular, hypothermic and endocrine responses. Neuroscience 1995, 64:675-685.
13. Conboy L., Tanrikut C., Zoladz P.R., Campbell A.M., Park C.R., Gabriel C., Mocaer E., Sandi C., Diamond D.M. The antidepressant agomelatine blocks the adverse effects of stress on memory and enables spatial learning to rapidly increase neural cell adhesion molecule (NCAM) expression in the hippocampus of rats. Int. J. Neuropsychopharmacol. 2008, 1-13.
14. Dekeyne A., Mannoury la Cour C., Gobert A., Brocco M., Lejeune F., Serres F., Sharp T., Daszuta A., Soumier A., Papp M., Rivet J.M., Flik G., Cremers T.I., Muller O., Lavielle G., Millan M.J. S32006, a novel 5-HT2C receptor antagonist displaying broad-based antidepressant and anxiolytic properties in rodent models. Psychopharmacology (Berl.) 2008, 199:549-568.
15. Fuchs E., Simon M., Schmelting B. Pharmacology of a new antidepressant: benefit of the implication of the melatonergic system. Int. Clin. Psychopharmacol. 2006, 21(Suppl. 1):S17-S20.
16. Goodwin G. Innovation translates into antidepressant effectiveness. J. Psychopharmacol. 2008, 22:9-12.
17. Gould E., Cameron H.A., Daniels D.C., Woolley C.S., McEwen B.S. Adrenal hormones suppress cell division in the adult rat dentate gyrus. J. Neurosci. 1992, 12:3642-3650.
18. Haritou S.J., Zylstra R., Ralli C., Turner S., Tortonese D.J. Seasonal changes in circadian peripheral plasma concentrations of melatonin, serotonin, dopamine and cortisol in aged horses with Cushing's disease under natural photoperiod. J. Neuroendocrinol. 2008, 20:988-996.
19. Herbert J. Neural systems underlying photoperiodic time measurement: a blueprint. Experientia 1989, 45:965-972.
20. Huang G.J., Herbert J. Stimulation of neurogenesis in the hippocampus of the adult rat by fluoxetine requires rhythmic change in corticosterone. Biol. Psychiatry 2006, 59:619-624.
21. Ichikawa J., Dai J., Meltzer H.Y. DOI, a 5-HT2A/2C receptor agonist, attenuates clozapine-induced cortical dopamine release. Brain Res. 2001, 907:151-155.
22. Jacobs B.L., Praag H., Gage F.H. Adult brain neurogenesis and psychiatry: a novel theory of depression. Mol. Psychiatry 2000, 5:262-269.
23. Lam R.W. High-quality remission: potential benefits of the melatonergic approach for patients with major depressive disorder. Int. Clin. Psychopharmacol. 2007, 22(Suppl. 2):S21-S25.
24. Lightman S.L., Wiles C.C., Atkinson H.C., Henley D.E., Russell G.M., Leendertz J.A., McKenna M.A., Spiga F., Wood S.A., Conway-Campbell B.L. The significance of glucocorticoid pulsatility. Eur. J. Pharmacol. 2008, 583:255-262.
25. Malberg J.E., Eisch A.J., Nestler E.J., Duman R.S. Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J. Neurosci. 2000, 20:9104-9110.
26. Millan M.J., Dekeyne A., Gobert A. Serotonin (5-HT)2C receptors tonically inhibit dopamine (DA) and noradrenaline (NA), but not 5-HT, release in the frontal cortex in vivo. Neuropharmacology 1998, 37:953-955.
27. Millan M.J., Gobert A., Lejeune F., Dekeyne A., Newman-Tancredi A., Pasteau V., Rivet J.M., Cussac D. The novel melatonin agonist agomelatine (S20098) is an antagonist at 5-hydroxytryptamine2C receptors, blockade of which enhances the activity of frontocortical dopaminergic and adrenergic pathways. J. Pharmacol. Exp. Ther. 2003, 306:954-964.
28. Ni Y.G., Miledi R. Blockage of 5HT2C serotonin receptors by fluoxetine (Prozac). Proc. Natl. Acad. Sci. U. S. A. 1997, 94:2036-2040.
29. O'Keeffe G.C., Barker R.A., Caldwell M.A. Dopaminergic modulation of neurogenesis in the subventricular zone of the adult brain. Cell Cycle 2009, 8:2888-2894.
30. Olie J.P., Kasper S. Efficacy of agomelatine, a MT1/MT2 receptor agonist with 5-HT2C antagonistic properties, in major depressive disorder. Int. J. Neuropsychopharmacol. 2007, 10:661-673.
31. Paizanis E., Renoir T., Lelievre V., Saurini F., Melfort M., Gabriel C., Barden N., Mocaer E., Hamon M., Lanfumey L. Behavioural and neuroplastic effects of the new-generation antidepressant agomelatine compared to fluoxetine in glucocorticoid receptor-impaired mice. Int. J. Neuropsychopharmacol. 2009, 1-16.
32. Pandi-Perumal S.R., Srinivasan V., Cardinali D.P., Monti M.J. Could agomelatine be the ideal antidepressant?. Expert Rev. Neurother. 2006, 6:1595-1608.
33. Papp M., Gruca P., Boyer P.A., Mocaer E. Effect of agomelatine in the chronic mild stress model of depression in the rat. Neuropsychopharmacology 2003, 28:694-703.
34. Pinnock S.B., Balendra R., Chan M., Hunt L.T., Turner-Stokes T., Herbert J. Interactions between nitric oxide and corticosterone in the regulation of progenitor cell proliferation in the dentate gyrus of the adult rat. Neuropsychopharmacology 2006, 32:493-504.
35. Ramirez-Rodriguez G., Klempin F., Babu H., Benitez-King G., Kempermann G. Melatonin modulates cell survival of new neurons in the hippocampus of adult mice. Neuropsychopharmacology 2009, 34:2180-2191.
36. Sanchez C., Hyttel J. Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding. Cell. Mol. Neurobiol. 1999, 19:467-489.
37. Santarelli L., Saxe M., Gross C., Surget A., Battaglia F., Dulawa S., et al. Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 2003, 301:805-809.
38. Soumier A., Banasr M., Lortet S., Masmejean F., Bernard N., Kerkerian-Le-Goff L., Gabriel C., Millan M.J., Mocaer E., Daszuta A. Mechanisms contributing to the phase-dependent regulation of neurogenesis by the novel antidepressant, agomelatine, in the adult rat hippocampus. Neuropsychopharmacology 2009, 34:2390-2403.
39. Stavreva D.A., Wiench M., John S., Conway-Campbell B.L., McKenna M.A., Pooley J.R., Johnson T.A., Voss T.C., Lightman S.L., Hager G.L. Ultradian hormone stimulation induces glucocorticoid receptor-mediated pulses of gene transcription. Nat. Cell Biol. 2009, 11:1093-1102.
40. Stein D.J., Ahokas A.A., de Bodinat C. Efficacy of agomelatine in generalized anxiety disorder: a randomized, double-blind, placebo-controlled study. J. Clin. Psychopharmacol. 2008, 28:561-566.
41. Waite E., Kershaw Y., Spiga F., Lightman S.L. A glucocorticoid sensitive biphasic rhythm of testosterone secretion. J. Neuroendocrinol. 2009, 21:737-741.
42. Wetterberg L. Melatonin and affective disorders. Ciba Found. Symp. 1985, 117:253-265.
43. Wong E.Y., Herbert J. Raised circulating corticosterone inhibits neuronal differentiation of progenitor cells in the adult hippocampus. Neuroscience 2006, 137:83-92.
44. Zupancic M., Guilleminault C. Agomelatine: a preliminary review of a new antidepressant. CNS Drugs 2006, 20:981-992.